RCS - Frontier IP Group - Elute Intelligence’s AI to back COVID-19 research

Frontier IPAnnouncement

30/03/2020 07:00

For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20200330:nRSd9591Ha

RNS Number : 9591H  Frontier IP Group plc  30 March 2020

RNS REACH

AIM: FIPP

30 March 2020

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Elute Intelligence uses novel artificial intelligence
technology to support scientists researching COVID-19

 

 

Frontier IP, a specialist in commercialising intellectual property, notes
today's announcement from portfolio company Elute Intelligence Holdings
Limited ("Elute") about the launch of a dedicated, free-to-use online COVID-19
Document Reader based on its novel artificial intelligence.

The Document Reader is aimed at supporting scientists researching the disease
and related coronaviruses by making it easier and quicker for them to find
relevant research. Frontier IP holds a 43 per cent equity stake in Elute.

 

Elute Intelligence launches dedicated COVID-19 Document Reader to help
scientists find vital research more rapidly

Elute Intelligence Holdings ("Elute") today announces it has launched a
dedicated free-to-use online COVID-19 Document Reader to help scientists
worldwide tackling the disease to find vital research more rapidly.

The COVID-19 Document Reader draws on Elute's novel advanced software tools to
intelligently search large and complex databases to identify relevant
information swiftly and effectively.  It is available at https://elute.info
(https://elute.info) .

The databases being used include a subset of PubMed, an online resource of
more than 30 million citations for papers drawn from Medline, life science
journals, books and other sources.  Researchers will be able to search this
for articles mentioning terms related to the current COVID-19 outbreak, such
as coronavirus, COVID, MERS, or SARS. Elute is proactively working with
researchers to identify additional datasets.

Elute's artificial intelligence searches, compares and analyses documents to
identify similarities between them by mimicking the way people read.
Researchers enter an entire paper already identified as of interest to find
other relevant research. They can also create their own documents defining
their own interests to enter into the Document Reader to refine searches still
further.

This means the approach is very different to conventional keyword or Boolean
search technologies.   A patent application has been filed to protect
developments of the technology.

Elute is already talking to a number of partners to support and publicise the
COVID-19 Document Reader.

Elute was incorporated last year from an existing UK business CFL Software
Limited and included complementary intellectual property developed by Frontier
IP. Existing customers include the Universities and Colleges Admissions
Service ("UCAS") which is using a version of the software called Copycatch to
detect plagiarism in students' personal statements. Others include academic
institutions, commercial researchers and lawyers.

Peter Fischer, Chief Executive Officer of Elute Intelligence, said: "We are
proud to be supporting the global fight against COVID-19 by exploiting our
unique capability in document search to support scientists in their crucial
research."

 

Matthew White, Chief Commercialisation Officer of Frontier IP Group, said:
"The COVID-19 Document Reader demonstrates just some of Elute's ability to
rapidly identify relevant information in unstructured datasets. It is great to
see the team deploy this capability in such a short space of time."

 

ENQUIRIES

 Frontier IP Group Plc                                              T: 020 7332 2338
 Neil Crabb, Chief Executive                                        neil@frontierip.co.uk
 Andrew Johnson, Communications and Investor Relations              M: 07464 546 025
 Group website: www.frontierip.co.uk (http://www.frontierip.co.uk)
 Allenby Capital Limited (Nominated Adviser)                        T: 0203 328 5656
 Nick Athanas / Nicholas Chambers

 

ABout frontier IP Group

Frontier IP unites science, finance and industry to build businesses based on
outstanding research.  It identifies strong intellectual property and
accelerates its development through a range of commercialisation services. A
critical part of the Group's work is involving relevant industry partners at
an early stage of development to ensure technology meets real world demands
and needs.

The Group looks to build and grow a portfolio of equity stakes and licence
income by taking an active involvement in spin-out companies, including
support for fund raising and collaboration with relevant industry partners at
an early stage of development.

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM quoted)
companies to distribute media only / non-regulatory news releases into the
public domain.   Information required to be notified under the AIM Rules for
Companies, Market Abuse Regulation or other regulation would be disseminated
as an RNS regulatory announcement and not on RNS Reach.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.   END  NRABCGDXRUDDGGC